中國心連心化肥(01866.HK)年度純利升9.85%至3.48億元 末期息每股10分
格隆匯 3 月 19日丨中國心連心化肥(01866.HK)公佈年度業績,截至2020年12月31日止年度,公司收入為人民幣104.45億元,同比增長16.99%;毛利為人民幣22.15億元,同比增長14.09%;母公司擁有人應占年度溢利為人民幣3.48億元,同比增長9.85%,基本及攤薄每股盈利為人民幣29.67分,擬派末期息每股人民幣10分。
2020年度,收入增加主要是由於複合肥、車用尿素溶液、甲醇、糠醇及醫藥中間體的銷售額增加所致,而該升幅部分被尿素、二甲醚(DME)及三聚氰胺銷售額下降所抵銷。
隨着中國進一步收緊環保政策,尿素及其他化工產品的價格將會繼續上升。此外,出口量的增加導致化肥需求增加,國內的尿素產品市場整體將會持續增長。
為了滿足市場需求、擴大肥料銷售覆蓋範圍及市場佔有率,集團一直穩步落實低成本和產品差異化戰略,進一步鞏固地理覆蓋範圍,形成中部、西北部和東南部三大戰略生產基地。位於江西省九江市的第三生產基地已於2021年2月成功投產。九江基地投產後。集團會充份利用水運優勢、技術優勢、產品質量優勢,在長江以南地區做好化肥和化工品市場,同時,積極擴張車用尿素出口貿易,進一步提高集團的行業地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.